Literature DB >> 14611875

Pathobiology of opisthorchiasis: an update.

Banchob Sripa1.   

Abstract

Opisthorchis viverrini infection is associated with several hepatobiliary diseases including cholangitis, obstructive jaundice, hepatomegaly, cholecystitis and cholelithiasis. Pathological consequences of O. viverrini infection occur mainly in the liver, extrahepatic bile ducts, gall bladder and kidney. These pathologies have been described in both humans and experimental animals. Moreover, both experimental and epidemiological evidence strongly implicate the liver fluke infection in the etiology of cholangiocarcinoma--the bile duct cancer. This review summarizes the pathology of opisthorchiasis from literature mainly published between 1970 and the present time and, particularly, emphasizes on current concept in pathogenesis of the disease. The theme is to highlight the new era of pathogenetic study of opisthorchiasis especially on host-parasite interaction and host immune/inflammatory responses leading to tissue damage.

Entities:  

Mesh:

Year:  2003        PMID: 14611875     DOI: 10.1016/j.actatropica.2003.08.002

Source DB:  PubMed          Journal:  Acta Trop        ISSN: 0001-706X            Impact factor:   3.112


  63 in total

1.  Apoptosis-related gene expression in hamster opisthorchiasis post praziquantel treatment.

Authors:  T Boonmars; P Srirach; B Kaewsamut; T Srisawangwong; S Pinlaor; P Pinlaor; P Yongvanit; P Sithithaworn
Journal:  Parasitol Res       Date:  2007-12-06       Impact factor: 2.289

2.  Biliary parasites: diagnostic and therapeutic strategies.

Authors:  Niraj Khandelwal; Joanna Shaw; Mamta K Jain
Journal:  Curr Treat Options Gastroenterol       Date:  2008-04

Review 3.  Opisthorchis viverrini: the carcinogenic human liver fluke.

Authors:  Natthawut Kaewpitoon; Soraya-J Kaewpitoon; Prasit Pengsaa; Banchob Sripa
Journal:  World J Gastroenterol       Date:  2008-02-07       Impact factor: 5.742

4.  Advanced periductal fibrosis from infection with the carcinogenic human liver fluke Opisthorchis viverrini correlates with elevated levels of interleukin-6.

Authors:  Banchob Sripa; Eimorn Mairiang; Bandit Thinkhamrop; Thewarach Laha; Sasithorn Kaewkes; Paiboon Sithithaworn; Smarn Tessana; Alex Loukas; Paul J Brindley; Jeffrey M Bethony
Journal:  Hepatology       Date:  2009-10       Impact factor: 17.425

5.  Intrahepatic cholangiocarcinoma with old infestation of Schistosoma japonicum: report of a case.

Authors:  Tomotaka Akatsu; Motohide Shimazu; Masahiro Shinoda; Shigeyuki Kawachi; Minoru Tanabe; Koichi Aiura; Masakazu Ueda; Kaori Kameyama; Michiie Sakamoto; Masaki Kitajima; Yuko Kitagawa
Journal:  Surg Today       Date:  2007-09-26       Impact factor: 2.549

Review 6.  The role of evolutionary biology in research and control of liver flukes in Southeast Asia.

Authors:  Pierre Echaubard; Banchob Sripa; Frank F Mallory; Bruce A Wilcox
Journal:  Infect Genet Evol       Date:  2016-05-16       Impact factor: 3.342

7.  Animal models for Opisthorchis viverrini infection.

Authors:  Thidarut Boonmars; Sirintip Boonjaraspinyo; Butsara Kaewsamut
Journal:  Parasitol Res       Date:  2008-12-03       Impact factor: 2.289

8.  Unlocking the transcriptomes of two carcinogenic parasites, Clonorchis sinensis and Opisthorchis viverrini.

Authors:  Neil D Young; Bronwyn E Campbell; Ross S Hall; Aaron R Jex; Cinzia Cantacessi; Thewarach Laha; Woon-Mok Sohn; Banchob Sripa; Alex Loukas; Paul J Brindley; Robin B Gasser
Journal:  PLoS Negl Trop Dis       Date:  2010-06-22

9.  A granulin-like growth factor secreted by the carcinogenic liver fluke, Opisthorchis viverrini, promotes proliferation of host cells.

Authors:  Michael J Smout; Thewarach Laha; Jason Mulvenna; Banchob Sripa; Sutas Suttiprapa; Alun Jones; Paul J Brindley; Alex Loukas
Journal:  PLoS Pathog       Date:  2009-10-09       Impact factor: 6.823

10.  Fishborne zoonotic intestinal trematodes, Vietnam.

Authors:  Do Trung Dung; Nguyen Van De; Jitra Waikagul; Anders Dalsgaard; Jong-Yil Chai; Woon-Mok Sohn; K Darwin Murrell
Journal:  Emerg Infect Dis       Date:  2007-12       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.